<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39408189</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2227-9032</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>19</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>08</Day></PubDate></JournalIssue><Title>Healthcare (Basel, Switzerland)</Title><ISOAbbreviation>Healthcare (Basel)</ISOAbbreviation></Journal><ArticleTitle>Impact of COVID-19 Pandemic on Healthcare Utilization in People with Diabetes: A Time-Segmented Longitudinal Study of Alberta's Tomorrow Project.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2009</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/healthcare12192009</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The objective is to characterize the impact of COVID-19 on major healthcare for diabetes, including hospitalization, emergency department (ED) visits and primary care visits in Alberta, Canada.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Participants from Alberta's Tomorrow Project (ATP) with pre-existing diabetes prior to 1 April 2018 were included and followed up to 31 March 2021. A time-segmented regression model was used to characterize the impact of COVID-19 on healthcare utilization after adjusting for seasonality, socio-demographic factors, lifestyle behaviors and comorbidity profile of patients.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Among 6099 participants (53.5% females, age at diagnosis 56.1 ± 9.9 y), the overall rate of hospitalization, ED visits and primary care visits was 151.5, 525.9 and 8826.9 per 1000 person-year during the COVID-19 pandemic (up to 31 March 2021), which means they reduced by 12% and 22% and increased by 6%, compared to pre-pandemic rates, respectively. Specifically, the first COVID-19 state of emergency (first wave of the outbreak) was associated with reduced rates of hospitalization, ED visits and primary care visits, by 79.4% (95% CI: 61.3-89.0%), 93.2% (95% CI: 74.6-98.2%) and 65.7% (95% CI: 47.3-77.7%), respectively. During the second state of emergency, healthcare utilization continued to decrease; however, a rebound (increase) of ED visits was observed during the period when the public health state of emergency was relaxed.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The declared COVID-19 states of emergency had a negative impact on healthcare utilization for people with diabetes, especially for hospital and ED services, which suggests the importance of enhancing the capacity of these two healthcare sectors during future COVID-19-like public health emergencies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ye</LastName><ForeName>Ming</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Public Health, University of Alberta, Edmonton, AB T6G 2G4, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vena</LastName><ForeName>Jennifer E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Alberta's Tomorrow Project, Cancer Care Alberta, Alberta Health Services, Calgary, AB T2T 5C7, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen-Tu</LastName><ForeName>Grace</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Alberta's Tomorrow Project, Cancer Care Alberta, Alberta Health Services, Calgary, AB T2T 5C7, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnson</LastName><ForeName>Jeffrey A</ForeName><Initials>JA</Initials><Identifier Source="ORCID">0000-0001-8290-2857</Identifier><AffiliationInfo><Affiliation>School of Public Health, University of Alberta, Edmonton, AB T6G 2G4, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eurich</LastName><ForeName>Dean T</ForeName><Initials>DT</Initials><Identifier Source="ORCID">0000-0003-2197-0463</Identifier><AffiliationInfo><Affiliation>School of Public Health, University of Alberta, Edmonton, AB T6G 2G4, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Healthcare (Basel)</MedlineTA><NlmUniqueID>101666525</NlmUniqueID><ISSNLinking>2227-9032</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">diabetes</Keyword><Keyword MajorTopicYN="N">healthcare utilization</Keyword><Keyword MajorTopicYN="N">public health emergency</Keyword></KeywordList><CoiStatement>The authors declared no conflict of interest. This study is based in part on data provided by Alberta Health. The interpretation and conclusions contained herein are those of the researchers and do not necessarily represent the views of the Government of Alberta. Neither the Government nor Alberta Health express any opinion in relation to this study.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>10</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>1</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39408189</ArticleId><ArticleId IdType="pmc">PMC11476217</ArticleId><ArticleId IdType="doi">10.3390/healthcare12192009</ArticleId><ArticleId IdType="pii">healthcare12192009</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Government of Alberta  Chief Medical Officer of Health Order: 2020 COVID-19 Response.  [(accessed on 14 July 2020)].  Available online:  https://open.alberta.ca/dataset?q=&amp;sort=metadata_created+desc&amp;pubtype=Orders+and+Directives&amp;tags=COVID-19.</Citation></Reference><Reference><Citation>Alberta Health Services, editor. Information for AHS Staff &amp; Health Professionals—The Novel Coronavirus (COVID-19) 2020.  [(accessed on 4 October 2024)].  Available online:  https://www.albertahealthservices.ca/topics/Page16947.aspx#resources.</Citation></Reference><Reference><Citation>Canadian Institute for Health Information  How COVID-19 Affected Emergency Departments.  [(accessed on 10 February 2021)].  Available online:  https://www.cihi.ca/en/covid-19-resources/impact-of-covid-19-on-canadas-health-care-systems/how-covid-19-affected.</Citation></Reference><Reference><Citation>Frankfurter C., Buchan T.A., Kobulnik J., Lee D.S., Luk A., McDonald M., Ross H.J., Alba A.C. Reduced rate of hospital presentations for heart failure during the COVID-19 pandemic in toronto, canada. Can. J. Cardiol. 2020;36:1680–1684. doi: 10.1016/j.cjca.2020.07.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjca.2020.07.006</ArticleId><ArticleId IdType="pmc">PMC7366087</ArticleId><ArticleId IdType="pubmed">32682855</ArticleId></ArticleIdList></Reference><Reference><Citation>Gregg E.W., Sophiea M.K., Weldegiorgis M. Diabetes and COVID-19: Population impact 18 months into the pandemic. Diabetes Care. 2021;44:1916–1923. doi: 10.2337/dci21-0001.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dci21-0001</ArticleId><ArticleId IdType="pubmed">34244333</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuschieri S., Grech S. COVID-19 and diabetes: The why, the what and the how. J. Diabetes Complicat. 2020;34:107637. doi: 10.1016/j.jdiacomp.2020.107637.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jdiacomp.2020.107637</ArticleId><ArticleId IdType="pmc">PMC7242955</ArticleId><ArticleId IdType="pubmed">32456846</ArticleId></ArticleIdList></Reference><Reference><Citation>Chudasama Y.V., Gillies C.L., Zaccardi F., Coles B., Davies M.J., Seidu S., Khunti K. Impact of COVID-19 on routine care for chronic diseases: A global survey of views from healthcare professionals. Diabetes Metab. Syndr. 2020;14:965–967. doi: 10.1016/j.dsx.2020.06.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2020.06.042</ArticleId><ArticleId IdType="pmc">PMC7308780</ArticleId><ArticleId IdType="pubmed">32604016</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye M., Robson P.J., Eurich D.T., Vena J.E., Xu J.Y., Johnson J.A. Cohort profile: Alberta’s tomorrow project. Int. J. Epidemiol. 2016;46:1097–1098. doi: 10.1093/ije/dyw256.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyw256</ArticleId><ArticleId IdType="pubmed">28338725</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathe N., Ryan A., Cook A., Sargious P., Senior P., Johnson J.A., Yeung R.O. Enhancing diabetes surveillance across alberta by adding laboratory and pharmacy data to the national diabetes surveillance system methods. Can. J. Diabetes. 2021;46:375–380. doi: 10.1016/j.jcjd.2021.12.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcjd.2021.12.001</ArticleId><ArticleId IdType="pubmed">35490092</ArticleId></ArticleIdList></Reference><Reference><Citation>Canadian Institute of Health Information . Canadian COVID-19 Intervention Timeline. Canadian Institute of Health Information; Ottawa, ON, Canada: 2022.</Citation></Reference><Reference><Citation>Gomez Y.M., Gallardo D.I., Leao J., Calsavara V.F. On a new piecewise regression model with cure rate: Diagnostics and application to medical data. Stat. Med. 2021;40:6723–6742. doi: 10.1002/sim.9208.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.9208</ArticleId><ArticleId IdType="pubmed">34581460</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown A.F., Mangione C.M., Saliba D., Sarkisian C.A., California Healthcare Foundation/American Geriatrics Society Panel on Improving Care for Elders with Diabetes Guidelines for improving the care of the older person with diabetes mellitus. J. Am. Geriatr. Soc. 2003;51:S265–S280.</Citation><ArticleIdList><ArticleId IdType="pubmed">12694461</ArticleId></ArticleIdList></Reference><Reference><Citation>Garriguet D. Diet quality in canada. Health Rep. 2009;20:41–52.</Citation><ArticleIdList><ArticleId IdType="pubmed">19813438</ArticleId></ArticleIdList></Reference><Reference><Citation>Quan H., Sundararajan V., Halfon P., Fong A., Burnand B., Luthi J.C., Saunders L.D., Beck C.A., Feasby T.E., Ghali W.A. Coding algorithms for defining comorbidities in icd-9-cm and icd-10 administrative data. Med. Care. 2005;43:1130–1139. doi: 10.1097/01.mlr.0000182534.19832.83.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.mlr.0000182534.19832.83</ArticleId><ArticleId IdType="pubmed">16224307</ArticleId></ArticleIdList></Reference><Reference><Citation>Moynihan R., Sanders S., Michaleff Z.A., Scott A.M., Clark J., To E.J., Jones M., Kitchener E., Fox M., Johansson M., et al. Impact of COVID-19 pandemic on utilisation of healthcare services: A systematic review. BMJ Open. 2021;11:e045343. doi: 10.1136/bmjopen-2020-045343.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-045343</ArticleId><ArticleId IdType="pmc">PMC7969768</ArticleId><ArticleId IdType="pubmed">33727273</ArticleId></ArticleIdList></Reference><Reference><Citation>de Mestral C., Gomez D., Wilton A.S., Lee D.S., Albalawi Z., Austin P.C., Jacob-Brassard J., Urbach D.R., Al-Omran M., Baxter N.N. A population-based analysis of diabetes-related care measures, foot complications, and amputation during the COVID-19 pandemic in ontario, canada. JAMA Netw. Open. 2022;5:e2142354. doi: 10.1001/jamanetworkopen.2021.42354.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.42354</ArticleId><ArticleId IdType="pmc">PMC8733837</ArticleId><ArticleId IdType="pubmed">34985514</ArticleId></ArticleIdList></Reference><Reference><Citation>Inglin L., Wikstrom K., Lamidi M.L., Laatikainen T. The adverse effect of the COVID-19 pandemic on health service usage among patients with type 2 diabetes in north karelia, finland. BMC Health Serv. Res. 2022;22:725. doi: 10.1186/s12913-022-08105-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-022-08105-z</ArticleId><ArticleId IdType="pmc">PMC9156619</ArticleId><ArticleId IdType="pubmed">35650580</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y.N., Chen Y., Wang Y., Li F., Pender M., Wang N., Yan F., Ying X.H., Tang S.L., Fu C.W. Reduction in healthcare services during the COVID-19 pandemic in china. BMJ Glob. Health. 2020;5:e003421. doi: 10.1136/bmjgh-2020-003421.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2020-003421</ArticleId><ArticleId IdType="pmc">PMC7662138</ArticleId><ArticleId IdType="pubmed">33184065</ArticleId></ArticleIdList></Reference><Reference><Citation>Moin J.S., Troke N., Plumptre L., Anderson G.M. Impact of the COVID-19 pandemic on diabetes care for adults with type 2 diabetes in ontario, canada. Can. J. Diabetes. 2022;46:715–721. doi: 10.1016/j.jcjd.2022.04.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcjd.2022.04.009</ArticleId><ArticleId IdType="pmc">PMC9059339</ArticleId><ArticleId IdType="pubmed">35953411</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng A.Y.Y., Harris S., Krawchenko I., Tytus R., Hahn J., Liu A., Millson B., Golden S., Goldenberg R. Impact of the COVID-19 pandemic on adults with type 2 diabetes care and clinical parameters in a primary care setting in ontario, canada: A cross-sectional study. Can. J. Diabetes. 2023;47:345–351. doi: 10.1016/j.jcjd.2023.01.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcjd.2023.01.003</ArticleId><ArticleId IdType="pmc">PMC9829439</ArticleId><ArticleId IdType="pubmed">36828737</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson E., Butt D.A., Gronsbell J., Ji C., O’Neill B., Crampton N., Tu K. Changes in the top 25 reasons for primary care visits during the COVID-19 pandemic in a high-covid region of canada. PLoS ONE. 2021;16:e0255992. doi: 10.1371/journal.pone.0255992.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0255992</ArticleId><ArticleId IdType="pmc">PMC8360367</ArticleId><ArticleId IdType="pubmed">34383844</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye M., Vena J.E., Shen-Tu G., Johnson J.A., Eurich D.T. Reduced incidence of diabetes during the COVID-19 pandemic in alberta: A time-segmented longitudinal study of alberta’s tomorrow project. Diabetes Obes. Metab. 2024;26:1244–1251. doi: 10.1111/dom.15420.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dom.15420</ArticleId><ArticleId IdType="pubmed">38131246</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng A.Y.Y., Goldenberg R., Krawchenko I., Tytus R., Hahn J., Liu A., Golden S., Millson B., Harris S. Impact of the COVID-19 pandemic on antihyperglycemic prescriptions for adults with type 2 diabetes in canada: A cross-sectional study. Can. J. Diabetes. 2023;47:398–404. doi: 10.1016/j.jcjd.2023.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcjd.2023.03.001</ArticleId><ArticleId IdType="pmc">PMC10029329</ArticleId><ArticleId IdType="pubmed">36958421</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai H.Y., Chou Y.J., Pu C. Continuity of care trajectories and emergency room use among patients with diabetes. Int. J. Public Health. 2015;60:505–513. doi: 10.1007/s00038-015-0671-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00038-015-0671-1</ArticleId><ArticleId IdType="pubmed">25779687</ArticleId></ArticleIdList></Reference><Reference><Citation>Weir D.L., McAlister F.A., Majumdar S.R., Eurich D.T. The interplay between continuity of care, multimorbidity, and adverse events in patients with diabetes. Med. Care. 2016;54:386–393. doi: 10.1097/MLR.0000000000000493.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MLR.0000000000000493</ArticleId><ArticleId IdType="pubmed">26807539</ArticleId></ArticleIdList></Reference><Reference><Citation>Saqib M.A.N., Siddiqui S., Qasim M., Jamil M.A., Rafique I., Awan U.A., Ahmad H., Afzal M.S. Effect of COVID-19 lockdown on patients with chronic diseases. Diabetes Metab. Syndr. 2020;14:1621–1623. doi: 10.1016/j.dsx.2020.08.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2020.08.028</ArticleId><ArticleId IdType="pmc">PMC7450263</ArticleId><ArticleId IdType="pubmed">32889403</ArticleId></ArticleIdList></Reference><Reference><Citation>Fekadu G., Bekele F., Tolossa T., Fetensa G., Turi E., Getachew M., Abdisa E., Assefa L., Afeta M., Demisew W., et al. Impact of COVID-19 pandemic on chronic diseases care follow-up and current perspectives in low resource settings: A narrative review. Int. J. Physiol. Pathophysiol. Pharmacol. 2021;13:86–93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8310882</ArticleId><ArticleId IdType="pubmed">34336132</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg S., Kim L., Whitaker M., O’Halloran A., Cummings C., Holstein R., Prill M., Chai S.J., Kirley P.D., Alden N.B., et al. Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019—COVID-net, 14 states, march 1–30, 2020. MMWR Morb. Mortal. Wkly. Rep. 2020;69:458–464. doi: 10.15585/mmwr.mm6915e3.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6915e3</ArticleId><ArticleId IdType="pmc">PMC7755063</ArticleId><ArticleId IdType="pubmed">32298251</ArticleId></ArticleIdList></Reference><Reference><Citation>Grasselli G., Zangrillo A., Zanella A., Antonelli M., Cabrini L., Castelli A., Cereda D., Coluccello A., Foti G., Fumagalli R., et al. Baseline characteristics and outcomes of 1591 patients infected with sars-cov-2 admitted to icus of the lombardy region, Italy. JAMA. 2020;323:1574–1581. doi: 10.1001/jama.2020.5394.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.5394</ArticleId><ArticleId IdType="pmc">PMC7136855</ArticleId><ArticleId IdType="pubmed">32250385</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Y., Carroll C., Vu K., Sen S., Georgiou A., Karaca-Mandic P. COVID-19 hospitalization trends in rural versus urban areas in the united states. Med. Care Res. Rev. MCRR. 2023;80:236–244. doi: 10.1177/10775587221111105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/10775587221111105</ArticleId><ArticleId IdType="pmc">PMC10011918</ArticleId><ArticleId IdType="pubmed">35848406</ArticleId></ArticleIdList></Reference><Reference><Citation>Larson A.E., Zahnd W.E., Davis M.M., Stange K.C., Yoon J., Heintzman J.D., Harvey S.M. Before and during pandemic telemedicine use: An analysis of rural and urban safety-net clinics. Am. J. Prev. Med. 2022;63:1031–1036. doi: 10.1016/j.amepre.2022.06.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amepre.2022.06.012</ArticleId><ArticleId IdType="pmc">PMC9462940</ArticleId><ArticleId IdType="pubmed">36096960</ArticleId></ArticleIdList></Reference><Reference><Citation>De Melo M., de Sa E., Gucciardi E. Exploring differences in canadian adult men and women with diabetes management: Results from the canadian community health survey. BMC Public Health. 2013;13:1089. doi: 10.1186/1471-2458-13-1089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2458-13-1089</ArticleId><ArticleId IdType="pmc">PMC3890645</ArticleId><ArticleId IdType="pubmed">24262007</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirkman M.S., Briscoe V.J., Clark N., Florez H., Haas L.B., Halter J.B., Huang E.S., Korytkowski M.T., Munshi M.N., Odegard P.S., et al. Diabetes in older adults. Diabetes Care. 2012;35:2650–2664. doi: 10.2337/dc12-1801.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc12-1801</ArticleId><ArticleId IdType="pmc">PMC3507610</ArticleId><ArticleId IdType="pubmed">23100048</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardt P.D., Brendel M.D., Kloer H.U., Bretzel R.G. Is pancreatic diabetes (type 3c diabetes) underdiagnosed and misdiagnosed? Diabetes Care. 2008;31((Suppl. 2)):S165–S169. doi: 10.2337/dc08-s244.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc08-s244</ArticleId><ArticleId IdType="pubmed">18227480</ArticleId></ArticleIdList></Reference><Reference><Citation>Stone M.A., Camosso-Stefinovic J., Wilkinson J., de Lusignan S., Hattersley A.T., Khunti K. Incorrect and incomplete coding and classification of diabetes: A systematic review. Diabet. Med. J. Br. Diabet. Assoc. 2010;27:491–497. doi: 10.1111/j.1464-5491.2009.02920.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1464-5491.2009.02920.x</ArticleId><ArticleId IdType="pubmed">20536944</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith M., Lix L.M., Azimaee M., Enns J.E., Orr J., Hong S., Roos L.L. Assessing the quality of administrative data for research: A framework from the manitoba centre for health policy. J. Am. Med. Inform. Assoc. 2018;25:224–229. doi: 10.1093/jamia/ocx078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocx078</ArticleId><ArticleId IdType="pmc">PMC7651885</ArticleId><ArticleId IdType="pubmed">29025002</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>